Evidence map›Paper›PMID 37213878›Full record

ReviewMethodist DeBakey cardiovascular journal2023

Transcatheter Aortic Valve Implantation: Long-Term Outcomes and Durability.

Parth V Desai, Sachin S Goel, Neal S Kleiman, Michael J Reardon

Abstract readReview
In one paragraph

Review in Methodist DeBakey cardiovascular journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Parth V DesaiLoyola University Medical Center, Maywood, Illinois, US.ORCID https://orcid.org/0000-0002-1302-0866
Sachin S GoelHouston Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, Texas, US.ORCID https://orcid.org/0000-0001-6041-3876
Neal S KleimanHouston Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, Texas, US.ORCID https://orcid.org/0000-0002-4334-8133
Michael J ReardonHouston Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, Texas, US.ORCID https://orcid.org/0000-0002-2880-6132

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transcatheter aortic valve implantation (TAVI) has become the standard of care in symptomatic older patients with severe aortic stenosis regardless of surgical risk. With the development of newer generation transcatheter bioprostheses, improved delivery systems, better preprocedure planning with imaging guidance, increased operator experience, shorter hospital length of stay, and low short- and mid-term complication rates, TAVI is gaining popularity among younger patients at low or intermediate surgical risk. Long-term outcomes and durability of transcatheter heart valves have become substantially important for this younger population due to their longer life expectancy. The lack of standardized definitions of bioprosthetic valve dysfunction and disagreement about how to account for the competing risks made comparison of transcatheter heart valves with surgical bioprostheses challenging until recently. In this review, the authors discuss the mid- to long-term (≥ 5 years) clinical outcomes observed in the landmark TAVI trials and analyze the available long-term durability data emphasizing the importance of using standardized definitions of bioprosthetic valve dysfunction.

Indexed as

Aortic Valve StenosisBioprosthesisHeart Valve ProsthesisTranscatheter Aortic Valve ReplacementAortic ValveHumansProsthesis FailureTreatment Outcomedurabilitylong-term outcomessevere aortic valve stenosisstructural valve degenerationsurgical aortic valve replacementtranscatheter aortic valve implantation

Identifiers

PMID37213878
PMCPMC10198228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.